Revvity Inc (RVTY)

$94.05 +2.59 (2.83%)
Market Cap 10.62B
Revenue (ttm) 2.76B
Net Income (ttm) 270.39M
EPS (ttm) N/A
PE Ratio 18.76
Forward PE 18.86
Profit Margin 9.81%
Debt to Equity Ratio 0.43
Volume 1,293,900
Avg Vol 1,337,746
Day's Range N/A - N/A
Shares Out 116.07M
Stochastic %K 93%
Beta 0.98
Analysts Strong Sell
Price Target $113.20

Company Profile

Revvity, Inc. provides health sciences solutions, technologies, and services. The company provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services; and instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and sc...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 781 663 6900
Address:
77 4th Avenue, Waltham, United States
TradeInYourJob
TradeInYourJob Oct. 5 at 1:49 AM
$RVTY no position currently but looks like a good add
0 · Reply
StockAutoPro
StockAutoPro Oct. 4 at 10:31 PM
$RVTY: Buy target $92.05 Sell target $98.75 Bullish trend in digital real estate could boost growth for leading virtual property platforms.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 4 at 12:43 AM
Enter: $RVTY NOV 21 2025 $95 CALLS Buy in Price: $3.93 - $4.10 Take Profit: $5.19 Stop Bleeding: $3.46 ROI Potential: 32% Exit Within: 109 Minutes https://moneygroup.us/alerts
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 2 at 7:23 PM
🏛️ 🚀 $RVTY up ⬆️10.39% since our entry $83.83 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 1 at 5:01 PM
🏛️ 🚀 $RVTY up ⬆️8.46% since our entry $83.83 on Sep 26, 2025 👉 FREE TRIAL! Check bio. ALL signals Time stamped. NO B.S.!
0 · Reply
highnihilism
highnihilism Oct. 1 at 11:49 AM
$RLJ RLJ Lodging Trust Trades: 3 | Total $: 551 | 0.39 × 90-Day Avg $: 1.4 K | Call $: 551 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $GYRE Gyre Therapeutics Trades: 2 | Total $: 550 | 0.04 × 90-Day Avg $: 13.6 K | Call $: 550 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $BFAM Bright Horizons Family Solutions Trades: 2 | Total $: 585 | 0.03 × 90-Day Avg $: 18.1 K | Call $: 550 | Put $: 35 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $RVTY Revvity Trades: 1 | Total $: 550 | 0.02 × 90-Day Avg $: 29.9 K | Call $: 550 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: –
0 · Reply
SPYmyQQQ
SPYmyQQQ Sep. 30 at 5:33 PM
🎯 Target Hit 🏁 📨 Signal From Sep 26, 2025 🏛️ $RVTY 💵 Entry: $83.8300 ✅ Exit: $86.6215 💰 P/L: +3.33% 👉 Check bio for full access
0 · Reply
SPYmyQQQ
SPYmyQQQ Sep. 26 at 3:02 PM
🚀 New Signal ✅ 🏛️ $RVTY 🗓️ Sep 26, 2025 💵 Entry: $83.83 🎯 Target (Opt.): $86.62 (+3.33%) 👉 Check bio for full access
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 26 at 2:01 AM
Enter: $RVTY OCT 17 2025 $85 CALLS Buy in Price: $3.90 - $5.00 Take Profit: $6.40 Stop Bleeding: $3.43 ROI Potential: 64% Exit Within: 288 Minutes https://moneygroup.us/alerts
0 · Reply
JarvisFlow
JarvisFlow Sep. 22 at 6:07 PM
B of A Securities updates rating for Revvity ( $RVTY ) to Buy, target set at 110 → 99.
0 · Reply
Latest News on RVTY
Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

Oct 2, 2025, 8:00 AM EDT - 2 days ago

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

SNY

Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis

Sep 29, 2025, 8:00 AM EDT - 5 days ago

Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis

Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems

Sep 22, 2025, 8:00 AM EDT - 12 days ago

Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems

Revvity, Inc. (RVTY) Presents At Baird 2025 Global Healthcare Conference (Transcript)

Sep 9, 2025, 5:31 PM EDT - 25 days ago

Revvity, Inc. (RVTY) Presents At Baird 2025 Global Healthcare Conference (Transcript)

Revvity, Inc. (RVTY) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 3, 2025, 10:40 AM EDT - 4 weeks ago

Revvity, Inc. (RVTY) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina

Sep 2, 2025, 8:00 AM EDT - 4 weeks ago

Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina

Revvity to Present at Upcoming Investor Conferences

Aug 18, 2025, 8:00 AM EDT - 6 weeks ago

Revvity to Present at Upcoming Investor Conferences

Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics

Aug 6, 2025, 8:00 AM EDT - 2 months ago

Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics

Revvity Q2: Headwinds From China And Customers, Buy On Weakness

Jul 28, 2025, 2:47 PM EDT - 2 months ago

Revvity Q2: Headwinds From China And Customers, Buy On Weakness

Revvity Stock Sinks on Lowered China Immunodiagnostics Outlook

Jul 28, 2025, 1:40 PM EDT - 2 months ago

Revvity Stock Sinks on Lowered China Immunodiagnostics Outlook

Top Stock Movers Now: Nike, Cheniere Energy, Revvity, and More

Jul 28, 2025, 12:25 PM EDT - 2 months ago

Top Stock Movers Now: Nike, Cheniere Energy, Revvity, and More

LNG NKE

Revvity, Inc. (RVTY) Q2 2025 Earnings Call Transcript

Jul 28, 2025, 11:59 AM EDT - 2 months ago

Revvity, Inc. (RVTY) Q2 2025 Earnings Call Transcript

ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Jul 28, 2025, 8:13 AM EDT - 2 months ago

ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session

ATAI

Revvity trims 2025 profit forecast on soft demand for diagnostics in China

Jul 28, 2025, 8:09 AM EDT - 2 months ago

Revvity trims 2025 profit forecast on soft demand for diagnostics in China

Revvity Stock Tumbles After Earnings. What's Dragging on the Shares.

Jul 28, 2025, 7:39 AM EDT - 2 months ago

Revvity Stock Tumbles After Earnings. What's Dragging on the Shares.

Revvity Announces Financial Results for the Second Quarter of 2025

Jul 28, 2025, 6:00 AM EDT - 2 months ago

Revvity Announces Financial Results for the Second Quarter of 2025

Revvity Board Declares Quarterly Dividend

Jul 24, 2025, 4:05 PM EDT - 2 months ago

Revvity Board Declares Quarterly Dividend

Revvity to Hold Earnings Call on Monday, July 28, 2025

Jul 7, 2025, 8:00 AM EDT - 3 months ago

Revvity to Hold Earnings Call on Monday, July 28, 2025

Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows

Jun 2, 2025, 8:00 AM EDT - 4 months ago

Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows

Revvity's EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing

May 19, 2025, 8:00 AM EDT - 4 months ago

Revvity's EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing

Revvity: Despite Facing Multiple Headwinds, Shares Are A Buy

May 9, 2025, 10:35 AM EDT - 5 months ago

Revvity: Despite Facing Multiple Headwinds, Shares Are A Buy

Revvity, Inc. (RVTY) Q1 2025 Earnings Call Transcript

Apr 28, 2025, 11:49 AM EDT - 5 months ago

Revvity, Inc. (RVTY) Q1 2025 Earnings Call Transcript

Life Science Tools Maker Revvity Delivers Strong Q1 Earnings Despite Evolving Macroeconomic Backdrop

Apr 28, 2025, 9:14 AM EDT - 5 months ago

Life Science Tools Maker Revvity Delivers Strong Q1 Earnings Despite Evolving Macroeconomic Backdrop

Revvity beats quarterly estimates on steady demand for medical equipment

Apr 28, 2025, 7:32 AM EDT - 5 months ago

Revvity beats quarterly estimates on steady demand for medical equipment

Revvity Announces Financial Results for the First Quarter of 2025

Apr 28, 2025, 6:00 AM EDT - 5 months ago

Revvity Announces Financial Results for the First Quarter of 2025

Watchmaker Genomics and Revvity Team to Automate and Streamline NGS Library Preparation

Apr 23, 2025, 8:00 AM EDT - 5 months ago

Watchmaker Genomics and Revvity Team to Automate and Streamline NGS Library Preparation

Revvity Fuels the Future of Cancer Science with New Research Solutions

Apr 22, 2025, 8:00 AM EDT - 5 months ago

Revvity Fuels the Future of Cancer Science with New Research Solutions

RSSS

Revvity to Hold Earnings Call on Monday, April 28, 2025

Apr 3, 2025, 8:00 AM EDT - 6 months ago

Revvity to Hold Earnings Call on Monday, April 28, 2025

Revvity Signals Software Unveils Unified Data Platform to Accelerate Drug Discovery

Apr 2, 2025, 8:00 AM EDT - 6 months ago

Revvity Signals Software Unveils Unified Data Platform to Accelerate Drug Discovery

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

Apr 2, 2025, 8:00 AM EDT - 6 months ago

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England

Mar 20, 2025, 1:00 PM EDT - 7 months ago

Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England

PerkinElmer Acquires Project Farma, Expanding Its OneSource Professional Services Offering for the Life Sciences Industry

Mar 11, 2025, 12:00 PM EDT - 7 months ago

PerkinElmer Acquires Project Farma, Expanding Its OneSource Professional Services Offering for the Life Sciences Industry

Revvity's EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Mar 3, 2025, 8:00 AM EST - 7 months ago

Revvity's EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group

Feb 20, 2025, 12:30 PM EST - 8 months ago

Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group

Revvity, Inc. (RVTY) Q4 2024 Earnings Call Transcript

Jan 31, 2025, 9:34 AM EST - 8 months ago

Revvity, Inc. (RVTY) Q4 2024 Earnings Call Transcript

Revvity forecasts 2025 revenue, profit below estimates amid weak biotech spending

Jan 31, 2025, 7:32 AM EST - 8 months ago

Revvity forecasts 2025 revenue, profit below estimates amid weak biotech spending

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024

Jan 31, 2025, 6:00 AM EST - 8 months ago

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024

Revvity Ignites Scientific Breakthroughs at SLAS2025

Jan 23, 2025, 8:00 AM EST - 9 months ago

Revvity Ignites Scientific Breakthroughs at SLAS2025

Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing

Jan 13, 2025, 8:00 AM EST - 9 months ago

Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing

Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance

Jan 12, 2025, 5:00 PM EST - 9 months ago

Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance

Revvity Announces FDA Clearance for First Automated Free Testosterone Test

Jan 10, 2025, 8:00 AM EST - 9 months ago

Revvity Announces FDA Clearance for First Automated Free Testosterone Test

Revvity to Present at J.P. Morgan Healthcare Conference

Dec 17, 2024, 8:00 AM EST - 10 months ago

Revvity to Present at J.P. Morgan Healthcare Conference

Safe Biopharma: Revvity's Recurring Revenues And Diagnostics

Dec 16, 2024, 12:27 AM EST - 10 months ago

Safe Biopharma: Revvity's Recurring Revenues And Diagnostics

Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst

Dec 13, 2024, 1:57 PM EST - 10 months ago

Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst

DHR

Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK

Nov 20, 2024, 8:00 AM EST - 11 months ago

Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK

Scale Biosciences and Revvity's BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells

Nov 19, 2024, 8:00 AM EST - 11 months ago

Scale Biosciences and Revvity's BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells

Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference

Nov 19, 2024, 8:00 AM EST - 11 months ago

Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference

Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation

Nov 18, 2024, 8:00 AM EST - 11 months ago

Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation

These Analysts Revise Their Forecasts On Revvity Following Q3 Results

Nov 5, 2024, 2:06 PM EST - 11 months ago

These Analysts Revise Their Forecasts On Revvity Following Q3 Results

Revitty (RVTY) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 12:30 PM EST - 11 months ago

Revitty (RVTY) Q3 2024 Earnings Call Transcript

TradeInYourJob
TradeInYourJob Oct. 5 at 1:49 AM
$RVTY no position currently but looks like a good add
0 · Reply
StockAutoPro
StockAutoPro Oct. 4 at 10:31 PM
$RVTY: Buy target $92.05 Sell target $98.75 Bullish trend in digital real estate could boost growth for leading virtual property platforms.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 4 at 12:43 AM
Enter: $RVTY NOV 21 2025 $95 CALLS Buy in Price: $3.93 - $4.10 Take Profit: $5.19 Stop Bleeding: $3.46 ROI Potential: 32% Exit Within: 109 Minutes https://moneygroup.us/alerts
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 2 at 7:23 PM
🏛️ 🚀 $RVTY up ⬆️10.39% since our entry $83.83 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 1 at 5:01 PM
🏛️ 🚀 $RVTY up ⬆️8.46% since our entry $83.83 on Sep 26, 2025 👉 FREE TRIAL! Check bio. ALL signals Time stamped. NO B.S.!
0 · Reply
highnihilism
highnihilism Oct. 1 at 11:49 AM
$RLJ RLJ Lodging Trust Trades: 3 | Total $: 551 | 0.39 × 90-Day Avg $: 1.4 K | Call $: 551 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $GYRE Gyre Therapeutics Trades: 2 | Total $: 550 | 0.04 × 90-Day Avg $: 13.6 K | Call $: 550 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $BFAM Bright Horizons Family Solutions Trades: 2 | Total $: 585 | 0.03 × 90-Day Avg $: 18.1 K | Call $: 550 | Put $: 35 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $RVTY Revvity Trades: 1 | Total $: 550 | 0.02 × 90-Day Avg $: 29.9 K | Call $: 550 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: –
0 · Reply
SPYmyQQQ
SPYmyQQQ Sep. 30 at 5:33 PM
🎯 Target Hit 🏁 📨 Signal From Sep 26, 2025 🏛️ $RVTY 💵 Entry: $83.8300 ✅ Exit: $86.6215 💰 P/L: +3.33% 👉 Check bio for full access
0 · Reply
SPYmyQQQ
SPYmyQQQ Sep. 26 at 3:02 PM
🚀 New Signal ✅ 🏛️ $RVTY 🗓️ Sep 26, 2025 💵 Entry: $83.83 🎯 Target (Opt.): $86.62 (+3.33%) 👉 Check bio for full access
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 26 at 2:01 AM
Enter: $RVTY OCT 17 2025 $85 CALLS Buy in Price: $3.90 - $5.00 Take Profit: $6.40 Stop Bleeding: $3.43 ROI Potential: 64% Exit Within: 288 Minutes https://moneygroup.us/alerts
0 · Reply
JarvisFlow
JarvisFlow Sep. 22 at 6:07 PM
B of A Securities updates rating for Revvity ( $RVTY ) to Buy, target set at 110 → 99.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 21 at 12:17 PM
Enter: $RVTY OCT 17 2025 $90 CALLS Buy in Price: $2.55 - $4.30 Take Profit: $3.82 Stop Bleeding: $2.24 ROI Potential: 50% Exit Within: 319 Minutes https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 19 at 11:53 AM
Enter: $RVTY OCT 17 2025 $90 CALLS Buy in Price: $2.20 - $2.95 Take Profit: $2.90 Stop Bleeding: $1.94 ROI Potential: 32% Exit Within: 276 Minutes https://moneygroup.us/alerts
0 · Reply
highnihilism
highnihilism Sep. 16 at 4:17 PM
S&P 500 → $AEE Ameren $PTC PTC $IR Ingersoll Rand $ESS Essex Property Trust $RVTY Revvity
0 · Reply
highnihilism
highnihilism Sep. 16 at 4:15 PM
S&P 500 → $AEE Ameren $PTC PTC $IR Ingersoll Rand $ESS Essex Property Trust $RVTY Revvity
0 · Reply
StockAutoPro
StockAutoPro Sep. 15 at 3:49 PM
$RVTY: Buy target $80.87 Sell target $87.01 RVTY sector's rising interest rates may negatively affect stock performance in the short term.
0 · Reply
smartkarma
smartkarma Sep. 12 at 2:21 AM
$RVTY | Revvity Is Balancing FX Gains, Margin Challenges, & Growth—Which Side Will Win Out? "Revvity Inc.'s Q2 2025 results reflect steady performance amidst challenging market and regulatory conditions. Organic revenue growth of 3% was achieved..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/revvity-is-balancing-fx-gains-margin-challenges-growth-which-side-will-win-out
0 · Reply
RunnerSignals
RunnerSignals Sep. 11 at 3:28 AM
Short sellers on edge! $CLH $ADP $NLY $RVTY $NOC who's squeezing next? Buckle up for a wild ride! https://stocksrunner.com/news/2025-09-10-high-short-interest-stocks-and-which-offer-the-best-near-term-opportunities
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 10 at 1:37 PM
$RVTY Excellent article that nails exactly where RVTY stands right now. So if you want to update your RVTY knowledge or get acquainted with RVTY, this is a must read. https://beyondspx.com/quote/RVTY/analysis/revvity-a-resilient-portfolio-and-technological-edge-amidst-macro-uncertainty-rvty
0 · Reply
StockAutoPro
StockAutoPro Sep. 8 at 2:07 AM
$RVTY: Buy target $84.64 Sell target $90.97 Expect potential growth in the RVTY sector due to increased consumer spending trends.
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Sep. 3 at 2:02 PM
$RVTY Pure valuation this should be in the $60’s
1 · Reply
StockAutoPro
StockAutoPro Aug. 31 at 6:53 AM
$RVTY: Buy target $88.11 Sell target $94.62 Consider diversifying portfolio with undervalued stocks in the RVTY sector for potential long-term gains.
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Aug. 27 at 4:43 PM
$RVTY glad I sold this 🐷… Horrible management
0 · Reply